A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...
for
B-All, Acute Lymphoblastic Leukemia
Location: Boston MA, Washington D.C. DC, Bethesda MD, Atlanta GA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 25
Code: NCT05621291
Recruiting
A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia
for
Leukemia, Juvenile Myelomonocytic, JMML, JCML,
Location: New York NY, Philadelphia PA, Baltimore MD,
Sponsor: Therapeutic Advances in Childhood Leukemia Consortium
Sex: All
Age: 0 - 21
Code: NCT05849662
Phase1, Phase2, Recruiting
In Vivo Metabolic Profiling of CLL (Chronic Lymphocytic Leukemia)
for
Chronic Lymphocytic Leukemia
Location: Madison WI
Sponsor: University of Wisconsin, Madison
Sex: All
Age: 18+
Code: NCT04785989
Recruiting
Orca-T Following Chemotherapy and Total Marrow and Lymphoid Irradiation for the Treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome
Get alerts for new trials in your area by subscribing now
Phase Ib/II Study Assessing the Clinical Activity and Safety of Brexucabtagene Autoleucel as a Consolidation in Patients With Relapsed/Refractory (R/R) and Newly Diagnosed B-cell Acute Lymphocytic Leukemia (ALL) Post Cytoreduction With Mini-HCVD-inotuzumab-blinatumomab/HCVAD-inotuzumab-blinatumomab
225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome
Location: Boston MA, Chapel Hill NC, Columbus OH, Atlanta GA
Sponsor: Christine Ryan
Sex: All
Age: 18+
Code: NCT06043674
Phase2, Recruiting
Effectiveness of Concurrent Ultra-Low-Dose Total-Skin Electron Beam Therapy and Brentuximab Vedotin Given Quarterly Over 12 Months for Patients With Mycosis Fungoides
for
Mycosis Fungoides
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT05357794
Phase2, Recruiting
Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy
for
Breast Carcinoma, Esophageal Carcinoma,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT00991094
Recruiting
Exercise Program (TEAM Me) for the Improvement of Movement and Mobility in Pediatric and Adolescent and Young Adult Patients With Cancer Undergoing a Blood Stem Cell Transplant